245 related articles for article (PubMed ID: 21667112)
21. Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China.
Huang CG; Liu T; Lv GD; Liu Q; Feng JG; Lu XM
Mol Biol Rep; 2012 Jan; 39(1):709-14. PubMed ID: 21553048
[TBL] [Abstract][Full Text] [Related]
22. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies.
Dai L; Wang K; Zhang J; Lv Q; Wu X; Wang Y
Int J Cancer; 2009 Sep; 125(5):1102-9. PubMed ID: 19444915
[TBL] [Abstract][Full Text] [Related]
23. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.
Yan Y; Liang H; Light M; Li T; Deng Y; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1907-15. PubMed ID: 24101192
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma.
Yu HP; Wang XL; Sun X; Su YH; Wang YJ; Lu B; Shi LY; Xiong CL; Li YY; Li F; Xu SQ
Cancer Genet Cytogenet; 2004 Oct; 154(1):10-5. PubMed ID: 15381366
[TBL] [Abstract][Full Text] [Related]
26. ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians.
Zhang J; Gu SY; Zhang P; Jia Z; Chang JH
Eur J Cancer; 2010 Sep; 46(13):2479-84. PubMed ID: 20627704
[TBL] [Abstract][Full Text] [Related]
27. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China.
Huang CG; Iv GD; Liu T; Liu Q; Feng JG; Lu XM
Biomarkers; 2011 Feb; 16(1):37-41. PubMed ID: 20979431
[TBL] [Abstract][Full Text] [Related]
29. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.
Zhan P; Wang Q; Wei SZ; Wang J; Qian Q; Yu LK; Song Y
J Thorac Oncol; 2010 Sep; 5(9):1337-45. PubMed ID: 20651612
[TBL] [Abstract][Full Text] [Related]
30. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis.
Duan XL; Gong H; Zeng XT; Ni XB; Yan Y; Chen W; Liu GL
Asian Pac J Cancer Prev; 2012; 13(7):3299-303. PubMed ID: 22994751
[TBL] [Abstract][Full Text] [Related]
31. XPD Lys
Yang QI; Wei YF; Zhang Y; Huang GM
Exp Ther Med; 2015 Jun; 9(6):2406-2414. PubMed ID: 26136996
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between the XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis.
Zhang T; Zhang DM; Zhao D; Hou XM; Ma SC; Liu XJ
Onco Targets Ther; 2014; 7():1255-60. PubMed ID: 25050067
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population.
Xing D; Qi J; Miao X; Lu W; Tan W; Lin D
Int J Cancer; 2002 Aug; 100(5):600-5. PubMed ID: 12124811
[TBL] [Abstract][Full Text] [Related]
34. DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies.
Wang F; Chang D; Hu FL; Sui H; Han B; Li DD; Zhao YS
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):507-17. PubMed ID: 18349268
[TBL] [Abstract][Full Text] [Related]
35. Association of XPD Lys751Gln gene polymorphism with susceptibility and clinical outcome of colorectal cancer in Pakistani population: a case-control pharmacogenetic study.
Gul S; Khan A; Raza A; Khan I; Ehtisham S
Genes Genomics; 2020 Dec; 42(12):1389-1398. PubMed ID: 33025549
[TBL] [Abstract][Full Text] [Related]
36. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
[TBL] [Abstract][Full Text] [Related]
37. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
[TBL] [Abstract][Full Text] [Related]
38. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
39. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
40. Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.
Gan Y; Li XR; Chen DJ; Wu JH
Asian Pac J Cancer Prev; 2012; 13(11):5721-4. PubMed ID: 23317245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
